A Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Doses of ZT006 Tablets in Healthy, Overweight, or Obese Subjects—A Randomized, Double-blind, Dose-escalation, Placebo-controlled Phase I Clinical Study
Latest Information Update: 16 Oct 2025
At a glance
- Drugs ZT 006 (Primary)
- Indications Obesity
- Focus Adverse reactions; First in man
Most Recent Events
- 16 Oct 2025 New trial record